Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CN Domestic Innovative Drugs Approved since 14th FYP Hit RMB100B in Mkt Size
Recommend 58 Positive 110 Negative 34 |
||||
|
||||
|
The 2024 China Pharmaceutical Industry Development Conference and the International Biopharmaceutical Industry Week Shanghai 2024 were held in Shanghai on 16 November, reported Xinhua News Agency. Since the 14th Five-Year Plan (FYP), the quantity and quality of domestic innovative drugs in mainland China have ascended in tandem, with a total of 113 domestic innovative drugs approved for marketing, which is 2.8 times the number of new drugs approved in the 13th FYP, with the market scale of RMB100 billion, based on the data released at the conference. Since the 14th FYP, the mainland China has accelerated innovation and breakthroughs in high-end medical devices. 165 innovative medical devices developed by Chinese enterprises have been approved for marketing, and the products incorporate cutting-edge technologies such as deep learning, magnetic levitation and additive manufacturing. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
